<?xml version="1.0" encoding="UTF-8"?>
<p>An important potential approach to COVID-19 control is the use of BCG vaccine
 <sup>
  <xref rid="cit0040" ref-type="bibr">40</xref>
 </sup> for COVID-19, which was developed by Jean-Marie Canille Guerin and Albert Calmette around 100Â years back for immunization against Tuberculosis (TB), one of the most dreaded human diseases caused by 
 <italic>M. tuberculosis</italic> (MTB). TB is predominant in developing countries and connected with poverty status, and control of TB is at least an issue of equity and human rights.
 <sup>
  <xref rid="cit0041" ref-type="bibr">41</xref>
 </sup> In areas with high burden of TB, control strategies for TB are overpowered by the rising cases of TB, occurring in parallel with HIV/AIDS pandemic.
 <sup>
  <xref rid="cit0042" ref-type="bibr">42</xref>
 </sup>
</p>
